TY - JOUR
T1 - Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment
AU - Bhoiwala, Devang L.
AU - Koleilat, Issam
AU - Qian, Jiang
AU - Beyer, Barbara
AU - Hushmendy, Shazaan F.
AU - Mathew, Alex
AU - Bhoiwala, Dipti L.
AU - Ferland, Russell J.
AU - Crawford, Dana R.
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Objectives: Recent evidence supports the involvement of RCAN1 in Down syndrome and Alzheimer's disease. To better assess this, we generated and analyzed transgenic mice overexpressing human RCAN1 isoform 4 in neurons. Methods: Cognitive behavioral (Morris water maze, open field, zero maze, elevated plus maze assays); cognitive-associated proteins (CREB, ERK and Tau Western immunoblotting); motor coordination (Rotarod assay); structural abnormalities (immunohistological analyses), and proinflammatory cytokines (cytometric bead assay) were measured in young (2 month) and old (18 month) transgenics and compared with wild type controls. Results: In old mice, male but not female transgenics exhibited a significant decrease in anxiety as compared with wild type controls, whereas female but not male transgenic mice exhibited significantly less motor coordination. No differences were observed in the Morris water maze (spatial learning). pERK levels were reduced in transgenic males but not females, while no differences were observed between genotypes for pCREB and pTau. In young mice, a modest learning and exploratory behavior was observed in transgenic mice using a limited number of mice, and at higher N values, pCREB and pERK (but not pTau) levels were reduced in transgenics. No macro- and micro-scopic structural abnormalities or proinflammatorycytokine level differences were observed. Discussion: These results indicate that elevated RCAN1 isoform 4 in neurons leads to a modest cognitionrelated impairment that is overall stronger at 2 months, suggesting a compensatory adaptation over time. These RCAN1 isoform 4 effects may contribute to at least some of the observed phenotypes in individuals with Down syndrome and Alzheimer's.
AB - Objectives: Recent evidence supports the involvement of RCAN1 in Down syndrome and Alzheimer's disease. To better assess this, we generated and analyzed transgenic mice overexpressing human RCAN1 isoform 4 in neurons. Methods: Cognitive behavioral (Morris water maze, open field, zero maze, elevated plus maze assays); cognitive-associated proteins (CREB, ERK and Tau Western immunoblotting); motor coordination (Rotarod assay); structural abnormalities (immunohistological analyses), and proinflammatory cytokines (cytometric bead assay) were measured in young (2 month) and old (18 month) transgenics and compared with wild type controls. Results: In old mice, male but not female transgenics exhibited a significant decrease in anxiety as compared with wild type controls, whereas female but not male transgenic mice exhibited significantly less motor coordination. No differences were observed in the Morris water maze (spatial learning). pERK levels were reduced in transgenic males but not females, while no differences were observed between genotypes for pCREB and pTau. In young mice, a modest learning and exploratory behavior was observed in transgenic mice using a limited number of mice, and at higher N values, pCREB and pERK (but not pTau) levels were reduced in transgenics. No macro- and micro-scopic structural abnormalities or proinflammatorycytokine level differences were observed. Discussion: These results indicate that elevated RCAN1 isoform 4 in neurons leads to a modest cognitionrelated impairment that is overall stronger at 2 months, suggesting a compensatory adaptation over time. These RCAN1 isoform 4 effects may contribute to at least some of the observed phenotypes in individuals with Down syndrome and Alzheimer's.
KW - Alzheimer's
KW - Cognitive impairment
KW - Down syndrome
KW - Neuronal expression
KW - RCAN1
UR - http://www.scopus.com/inward/record.url?scp=84872591871&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872591871&partnerID=8YFLogxK
U2 - 10.1179/1743132812Y.0000000117
DO - 10.1179/1743132812Y.0000000117
M3 - Article
C2 - 23317802
AN - SCOPUS:84872591871
SN - 0161-6412
VL - 35
SP - 79
EP - 89
JO - Neurological Research
JF - Neurological Research
IS - 1
ER -